Joep G.H. van Roermund

1.3k citations

41 papers · 914 indexed · h-index 20

Radiation top 5%
- Advanced Radiotherapy Techniques 6
Pulmonary and Respiratory Medicine top 5%
- Prostate Cancer Diagnosis and Treatment 20
- Prostate Cancer Treatment and Research 16
- Renal cell carcinoma treatment 3
Urology top 5%
- Urinary Bladder and Prostate Research 4
Cancer Research
Oncology
- Cancer Risks and Factors 5
Surgery
- Bladder and Urothelial Cancer Treatments 7
Molecular Biology
- Epigenetics and DNA Methylation 3

Co-authors: Marco van Vulpen Karel A. Hinnen Jan J. Battermann J. Alfred Witjes Lambertus A. Kiemeney Evelyn M. Monninkhof Steven J. Frank J.L.H. Ruud Bosch
Cited by: Radiation Pulmonary and Respiratory Medicine Urology
Partner nations: Netherlands United States Germany

In The Last Decade

Joep G.H. van Roermund

35 papers receiving 900 citations

Peers

Countries citing papers authored by Joep G.H. van Roermund

Since Specialization

Citations

This map shows the geographic impact of Joep G.H. van Roermund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joep G.H. van Roermund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joep G.H. van Roermund more than expected).

Fields of papers citing papers by Joep G.H. van Roermund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joep G.H. van Roermund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joep G.H. van Roermund. The network helps show where Joep G.H. van Roermund may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Joep G.H. van Roermund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joep G.H. van Roermund Line = papers co-authored together Joep G.H. van Roermund links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Bladder outlet obstruction surgery in patients undergoing radiation therapy for prostate cancer: Adverse events, functional outcomes and quality of life — A scoping review Casper Vrij,John Heesakkers,Evert J. Van Limbergen,Marc de Jong,Ronald A. Bos,Dennis Oerlemans,H.M. Bruins,Nathalie Biemold,Tom Marcellissen,Kevin Rademakers,Peter de Vries,Elisabeth J.M. Driessen,Frits van Osch,Joep G.H. van Roermund,Tom J.N. Hermans	2025	0
2	Renal cell carcinoma detection: a systematic review in diagnostic urinary biomarkers John J. Kelly,Iryna Samarska,Bram Ramaekers,Tom Marcelissen,Joep G.H. van Roermund,Maureen J.B. Aarts,Thomas Kerkhofs,Tom J.N. Hermans,Frits van Osch,Tim De Meyer,Leo J. Schouten,Kim M. Smits	2025	0
3	Benefits of resistance training are not preserved after cessation of supervised training in prostate cancer patients on androgen deprivation therapy Lisanne H. P. Houben,Maarten Overkamp,Joan M. Senden,Joep G.H. van Roermund,Peter de Vries,K. De Laet,Saskia van der Meer,Luc J. C. van Loon,Milou Beelen,Sandra Beijer	2024	0
4	Onset of androgen deprivation therapy leads to rapid deterioration of body composition, physical performance, cardiometabolic health and quality-of-life in prostate cancer patients Maarten Overkamp,Lisanne H. P. Houben,Saskia van der Meer,Joep G.H. van Roermund,Ronald A. Bos,Arjan P. J. Kokshoorn,Mads S. Larsen,Luc J. C. van Loon,Milou Beelen,Sandra Beijer	2023	5
5	A comparison of machine learning models for predicting urinary incontinence in men with localized prostate cancer Hajar Hasannejadasl,Biche Osong,Iñigo Bermejo,Henk G. van der Poel,Ben Vanneste,Joep G.H. van Roermund,Katja K.H. Aben,Zhen Zhang,Lambertus A. Kiemeney,Inge M. van Oort,Renée Verwey,Laura Hochstenbach,Esther Bloemen,André Dekker,Rianne Fijten	2023	6
6	Development and external validation of multivariate prediction models for erectile dysfunction in men with localized prostate cancer Hajar Hasannejadasl,Cheryl Roumen,Henk G. van der Poel,Ben Vanneste,Joep G.H. van Roermund,Katja K.H. Aben,Petros Kalendralis,Biche Osong,Lambertus A. Kiemeney,Inge M. van Oort,Renée Verwey,Laura Hochstenbach,Esther J. Bloemen- van Gurp,André Dekker,Rianne Fijten	2023	6
7	Is prostate cancer radiotherapy using implantable rectum spacers safe and effective in inflammatory bowel disease patients? Ben Vanneste,Evert J. Van Limbergen,Tom Marcelissen,Kobe Reynders,Jarno Melenhorst,Joep G.H. van Roermund,Ludy Lutgens	2021	6
8	Diagnostic DNA Methylation Biomarkers for Renal Cell Carcinoma: A Systematic Review Kim Lommen,Nathalie Vaes,Maureen J.B. Aarts,Joep G.H. van Roermund,Leo J. Schouten,Egbert Oosterwijk,Veerle Melotte,Vivianne C. G. Tjan‐Heijnen,Manon van Engeland,Kim M. Smits	2019	18
9	Multifaceted Mechanisms of Cisplatin Resistance in Long-Term Treated Urothelial Carcinoma Cell Lines Margaretha A. Skowron,Margarita Melnikova,Joep G.H. van Roermund,Andrea Romano,Peter Albers,Jürgen Thomale,Wolfgang A. Schulz,Günter Niegisch,Michèle J. Hoffmann	2018	34
10	Phenotype plasticity rather than repopulation from CD90/CK14+ cancer stem cells leads to cisplatin resistance of urothelial carcinoma cell lines Margaretha A. Skowron,Günter Niegisch,Gerhard Fritz,Tanja Arent,Joep G.H. van Roermund,Andrea Romano,Peter Albers,Wolfgang A. Schulz,Michèle J. Hoffmann	2015	25
11	Prostate Brachytherapy and Second Primary Cancer Risk: A Competitive Risk Analysis Karel A. Hinnen,Michael Schaapveld,Marco van Vulpen,Jan J. Battermann,Henk G. van der Poel,Inge M. van Oort,Joep G.H. van Roermund,Evelyn M. Monninkhof	2011	66
12	Blood lipid levels and prostate cancer risk; a cohort study Dieuwertje E. Kok,Joep G.H. van Roermund,Katja K.H. Aben,Martin den Heijer,Dorine W. Swinkels,Ellen Kampman,Lambertus A. Kiemeney	2011	42
13	Acute Urinary Retention After I-125 Prostate Brachytherapy in Relation to Dose in Different Regions of the Prostate Ellen M.A. Roeloffzen,Evelyn M. Monninkhof,Jan J. Battermann,Joep G.H. van Roermund,Marinus A. Moerland,Marco van Vulpen	2010	16
14	Periprostatic fat correlates with tumour aggressiveness in prostate cancer patients Joep G.H. van Roermund,Karel A. Hinnen,Christine Tolman,Gijsbert H. Bol,J. Alfred Witjes,J.L.H. Ruud Bosch,Lambertus A. Kiemeney,Marco van Vulpen	2010	80
15	Loose seeds versus stranded seeds in I-125 prostate brachytherapy: Differences in clinical outcome Karel A. Hinnen,Marinus A. Moerland,Jan J. Battermann,Joep G.H. van Roermund,Evelyn M. Monninkhof,Ina M. Jürgenliemk‐Schulz,Marco van Vulpen	2010	22
16	Pretreatment Nomogram to Predict the Risk of Acute Urinary Retention After I-125 Prostate Brachytherapy Ellen M.A. Roeloffzen,Marco van Vulpen,Jan J. Battermann,Joep G.H. van Roermund,Elantholi P. Saibishkumar,Evelyn M. Monninkhof	2010	17
17	Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer Dieuwertje E. Kok,Joep G.H. van Roermund,Katja K.H. Aben,Moniek W.M. van de Luijtgaarden,Herbert F.M. Karthaus,Oncko B. van Vierssen Trip,Ellen Kampman,J. Alfred Witjes,Lambertus A. Kiemeney	2010	12
18	Survival after prostate brachytherapy in patients aged 60 years and younger Karel A. Hinnen,Ellen M.A. Roeloffzen,Jan J. Battermann,R. Jeroen A. van Moorselaar,Joep G.H. van Roermund,Marco van Vulpen	2010	5
19	Periprostatic fat measured on computed tomography as a marker for prostate cancer aggressiveness Joep G.H. van Roermund,Gijsbert H. Bol,J. Alfred Witjes,J.L.H. Ruud Bosch,Lambertus A. Kiemeney,Marco van Vulpen	2009	35
20	Body mass index is not a prognostic marker for prostate‐specific antigen failure and survival in Dutch men treated with brachytherapy Joep G.H. van Roermund,Karel A. Hinnen,Jan J. Battermann,J. Alfred Witjes,J.L.H. Ruud Bosch,Lambertus A. Kiemeney,Marco van Vulpen	2009	30

About Joep G.H. van Roermund

Joep G.H. van Roermund is a scholar working on Urology, Pulmonary and Respiratory Medicine and Radiation, having authored 41 papers that have together received 914 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (20 papers), Prostate Cancer Treatment and Research (16 papers), Bladder and Urothelial Cancer Treatments (7 papers), Advanced Radiotherapy Techniques (6 papers), Cancer Risks and Factors (5 papers), Urinary Bladder and Prostate Research (4 papers), Renal cell carcinoma treatment (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Radiation (157 citations), Pulmonary and Respiratory Medicine (573 citations) and Urology (75 citations). Joep G.H. van Roermund has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Marco van Vulpen, Karel A. Hinnen, Jan J. Battermann, J. Alfred Witjes, Lambertus A. Kiemeney, Evelyn M. Monninkhof, Steven J. Frank, J.L.H. Ruud Bosch, Marinus A. Moerland and Tom Marcelissen.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact